Health and illness beliefs in adults with tuberculosis infection during the COVID-19 pandemic in the UK
© 2023 Published by Elsevier Inc. CC BY-NC-ND 4.0..
Background: COVID-19 disrupted the TB prevention programme in the UK, especially for TB infection (TBI) care. We explore whether experience of the COVID-19 pandemic impacted on patients' perceptions of TBI and its treatment.
Methods: Semi-structured interviews were conducted as part of the Research to Improve Detection and Treatment of TBI (RID-TB) programme, exploring perceptual and practical barriers to TBI treatment. Nineteen people diagnosed with TBI were interviewed between August 2020 and April 2021. Recordings were transcribed and analysed using a constant comparative approach, allowing for a dynamic and iterative exploration of themes. Themes are organised using the Perceptions and Practicalities Approach.
Findings: Some participants perceived TBI as a risk factor for increased susceptibility to COVID-19, while some thought that treatment for TBI might protect against COVID-19 or mitigate its effects. Adaptations to TB services (e.g., remote follow-up) and integrated practices during the COVID-19 restrictions (e.g., medication being posted) addressed some practical barriers to TBI treatment. However, we identified beliefs about TBI and COVID-19 that are likely to act as barriers to engagement with TBI treatment, including: interpreting service delays as an indication of TBI not being serious enough for treatment and concerns about contracting COVID-19 in TB clinics.
Interpretation: COVID-19 and TBI service delays influence people's perceptions and practical barriers to TBI treatment adherence. Failure to address these beliefs may lead to people's concerns about their treatment not being fully addressed. Utilised service adaptations like remote consultations to address practical barriers may be relevant beyond COVID-19.
Funding: NIHR RID-TB Program (RP-PG-0217-20009).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Dialogues in health - 4(2024) vom: 20. März, Seite 100162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kılıç, Ayşenur [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Covid-19 |
|---|
| Anmerkungen: |
Date Revised 23.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.dialog.2023.100162 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370057988 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370057988 | ||
| 003 | DE-627 | ||
| 005 | 20240323235816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.dialog.2023.100162 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1343.xml |
| 035 | |a (DE-627)NLM370057988 | ||
| 035 | |a (NLM)38516222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kılıç, Ayşenur |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Health and illness beliefs in adults with tuberculosis infection during the COVID-19 pandemic in the UK |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Published by Elsevier Inc. CC BY-NC-ND 4.0. | ||
| 520 | |a Background: COVID-19 disrupted the TB prevention programme in the UK, especially for TB infection (TBI) care. We explore whether experience of the COVID-19 pandemic impacted on patients' perceptions of TBI and its treatment | ||
| 520 | |a Methods: Semi-structured interviews were conducted as part of the Research to Improve Detection and Treatment of TBI (RID-TB) programme, exploring perceptual and practical barriers to TBI treatment. Nineteen people diagnosed with TBI were interviewed between August 2020 and April 2021. Recordings were transcribed and analysed using a constant comparative approach, allowing for a dynamic and iterative exploration of themes. Themes are organised using the Perceptions and Practicalities Approach | ||
| 520 | |a Findings: Some participants perceived TBI as a risk factor for increased susceptibility to COVID-19, while some thought that treatment for TBI might protect against COVID-19 or mitigate its effects. Adaptations to TB services (e.g., remote follow-up) and integrated practices during the COVID-19 restrictions (e.g., medication being posted) addressed some practical barriers to TBI treatment. However, we identified beliefs about TBI and COVID-19 that are likely to act as barriers to engagement with TBI treatment, including: interpreting service delays as an indication of TBI not being serious enough for treatment and concerns about contracting COVID-19 in TB clinics | ||
| 520 | |a Interpretation: COVID-19 and TBI service delays influence people's perceptions and practical barriers to TBI treatment adherence. Failure to address these beliefs may lead to people's concerns about their treatment not being fully addressed. Utilised service adaptations like remote consultations to address practical barriers may be relevant beyond COVID-19 | ||
| 520 | |a Funding: NIHR RID-TB Program (RP-PG-0217-20009) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a LTBI | |
| 650 | 4 | |a health beliefs | |
| 650 | 4 | |a perceptions | |
| 650 | 4 | |a tuberculosis | |
| 700 | 1 | |a Clarke, Amy L |e verfasserin |4 aut | |
| 700 | 1 | |a Moon, Zoe |e verfasserin |4 aut | |
| 700 | 1 | |a Hamada, Yohhei |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Amy Hai Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Rahman, Ananna |e verfasserin |4 aut | |
| 700 | 1 | |a Layton, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Griffiths, Chris J |e verfasserin |4 aut | |
| 700 | 1 | |a Zenner, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Powell, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Kunst, Heinke |e verfasserin |4 aut | |
| 700 | 1 | |a Lipman, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Mandelbaum, Mike |e verfasserin |4 aut | |
| 700 | 1 | |a Papineni, Padmasayee |e verfasserin |4 aut | |
| 700 | 1 | |a Tattersall, Tessa |e verfasserin |4 aut | |
| 700 | 1 | |a Duong, Trinh |e verfasserin |4 aut | |
| 700 | 1 | |a Abubakar, Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Rangaka, Molebogeng X |e verfasserin |4 aut | |
| 700 | 1 | |a Horne, Robert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Dialogues in health |d 2022 |g 4(2024) vom: 20. März, Seite 100162 |w (DE-627)NLM350420483 |x 2772-6533 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2024 |g day:20 |g month:03 |g pages:100162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dialog.2023.100162 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2024 |b 20 |c 03 |h 100162 | ||